SCHEMBL7697304

SCHEMBL7697304

Fc1ccccc1N1CCN(c2cnc3cc4ccccc4cc3n2)CC1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.77
▸ SMN1; SMN2 Q16637 5/20 0.77
▸ NFKB1 P19838 2/20 0.77
▸ NFKB2 Q00653 2/20 0.77
▸ RELA Q04206 2/20 0.77
▸ LMNA P02545 2/20 0.77
▸ NPSR1 Q6W5P4 2/20 0.77
▸ NPC1 O15118 7/20 0.50
▸ RAB9A P51151 6/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ ALDH1A1 P00352 5/20 0.49
▸ GAA P10253 2/20 0.49
▸ HPGD P15428 2/20 0.49
▸ KDM4E B2RXH2 2/20 0.49
▸ GLA P06280 1/20 0.49
▸ HRH4 Q9H3N8 2/20 0.48
▸ HTR3A P46098 1/20 0.48
▸ HTT P42858 1/20 0.48
▸ RXFP1 Q9HBX9 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7698573 0.93 MAPT (0.67) MAPTSMN1; SMN2NFKB1NFKB2RELA
SCHEMBL7690144 0.81 NPC1 (0.77) MAPTSMN1; SMN2NFKB1NFKB2RELA
SCHEMBL7695990 0.80 NPC1 (0.64) MAPTSMN1; SMN2NFKB1NFKB2RELA
SCHEMBL7697600 0.80 MAPT (0.74) MAPTSMN1; SMN2NFKB1NFKB2RELA
SCHEMBL7693429 0.80 HTR3A (0.74) MAPTSMN1; SMN2NFKB1NFKB2RELA
SCHEMBL7694046 0.79 NPC1 (0.51) MAPTSMN1; SMN2NFKB1NFKB2RELA
SCHEMBL7699332 0.78 MAPT (0.51) MAPTSMN1; SMN2NFKB1NFKB2RELA
SCHEMBL7697028 0.78 NPC1 (0.61) MAPTSMN1; SMN2NFKB1NFKB2RELA
SCHEMBL7689945 0.77 MAPT (0.53) MAPTSMN1; SMN2NFKB1NFKB2RELA
SCHEMBL30808190 0.75 MAPT (0.60) MAPTSMN1; SMN2NFKB1NFKB2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002094796-A2 BENZO[G]QUINOXALINE DERIVATIVES AS EFFECTIVE COMPOUNDS AGAINST INFECTIOUS DISEASES AXXIMA PHARMACEUTICALS AG (DE) 2002-11-28 — — WO disclosed
Send feedback